We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




The TandemHeart PTVA System

By HospiMedica staff writers
Posted on 20 Feb 2007
A short-term extracorporeal circulatory support system provides cardiac assistance through a percutaneous cardiac catheterization procedure in as little as 30 minutes.

The TandemHeart percutaneous transseptal ventricular assist (PTVA) system is a left ventricular assist device (LVAD) designed to be used as a short-term circulatory support system for procedures not requiring complete cardiopulmonary bypass. More...
The system is comprised of three elements: The TandemHeart pump provides the circulating power to pull oxygenated blood from the left atrium and to return it to the systemic arterial circulation; the TandemHeart cannula set connects the pump to the body by way of two percutaneous access points in the patient's groin; and the TandemHeart controller provides operating power to the pump, a controlled flow of lubricant to the pump, and automatic system monitoring and alarms indicating conditions that require attention.

A recently introduced lightweight, space-saving escort controller is also available, which can be mounted at bedside, on an intravenous (IV) pole, or on a table top. It is intended primarily for alternating current (AC) power use, but has enough battery back-up power for an hour of operation. The TandemHeart PTVA system is a product of CardiacAssist (Pittsburgh, PA, USA), and has been approved by the U.S. Food and Drug Administration (FDA) for short-term use for up to six hours.

"The clinical experience with TandemHeart is now very substantial,” said CardiacAssist CEO Michael Garippa. "Design improvements have made the system more portable and capable of delivering up to 5 l/min of critical blood flow. We're very excited about the prospects for 2007 as our technology continues to be adopted by hospitals and institutions in the United States and around the world.”


Related Links:
CardiacAssist

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.